Cronos Group Inc vs Xylem, Inc. — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.14B), while Xylem, Inc. trades at $123.99 (market cap $28.76B). The key difference: Xylem, Inc. is far larger — about 25.2× Cronos Group Inc's market cap, and Xylem, Inc. pays a 1.4% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | XYL | |
|---|---|---|
Market Cap | $1.14B | $28.76B |
Sector | Health | Industrials |
52-Week High | $3.27 | $152.95 |
52-Week Low | $2.30 | $106.34 |
Enterprise Value | $341.13M | $30.54B |
Dividend Yield | — | 1.4% |
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →